Search research articles
Contact Us
Filters
Showing results (661-670 of 671) with videos related to
Page
of 68
Sort By:
Plos Medicine
|
June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
Gary J Weil, Joshua Bogus, Michael Christian, et al.
Cancer Science
|
July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
Ozge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Plos One
|
June 28, 2013
Two Distinct Categories of Focal Deletions in Cancer Genomes
Megha Rajaram, Jianping Zhang, Tim Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Plos Neglected Tropical Diseases
|
March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Plos Neglected Tropical Diseases
|
January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis
Katherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Plos Neglected Tropical Diseases
|
December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation
Brian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 6, 2010
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study
Adrian F Daly, Maria A Tichomirowa, Patrick Petrossians, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 671) with videos related to
Sort By:
Page
of 68
Plos Medicine
|
June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
Gary J Weil, Joshua Bogus, Michael Christian, et al.
Cancer Science
|
July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
Ozge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Plos One
|
June 28, 2013
Two Distinct Categories of Focal Deletions in Cancer Genomes
Megha Rajaram, Jianping Zhang, Tim Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Plos Neglected Tropical Diseases
|
March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Plos Neglected Tropical Diseases
|
January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis
Katherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Plos Neglected Tropical Diseases
|
December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation
Brian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 6, 2010
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study
Adrian F Daly, Maria A Tichomirowa, Patrick Petrossians, et al.
Page
of 68